Respiratory Medicine
Volume 106, Issue 3 , Pages 436-442, March 2012

Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures

  • Koji Sakamoto

      Affiliations

    • Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan
    • Department of Respiratory Medicine and Allergy, Tosei General Hospital, Nishioiwake-cho, Seto-shi, Aichi 489-8642, Japan
  • ,
  • Hiroyuki Taniguchi

      Affiliations

    • Department of Respiratory Medicine and Allergy, Tosei General Hospital, Nishioiwake-cho, Seto-shi, Aichi 489-8642, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 561 82 5101x7309; fax: +81 561 82 9139.
  • ,
  • Yasuhiro Kondoh

      Affiliations

    • Department of Respiratory Medicine and Allergy, Tosei General Hospital, Nishioiwake-cho, Seto-shi, Aichi 489-8642, Japan
  • ,
  • Kenji Wakai

      Affiliations

    • Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Japan
  • ,
  • Tomoki Kimura

      Affiliations

    • Department of Respiratory Medicine and Allergy, Tosei General Hospital, Nishioiwake-cho, Seto-shi, Aichi 489-8642, Japan
  • ,
  • Kensuke Kataoka

      Affiliations

    • Department of Respiratory Medicine and Allergy, Tosei General Hospital, Nishioiwake-cho, Seto-shi, Aichi 489-8642, Japan
  • ,
  • Naozumi Hashimoto

      Affiliations

    • Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan
  • ,
  • Osamu Nishiyama

      Affiliations

    • Department of Pulmonary Medicine and Allergology, Kinki University School of Medicine, Japan
  • ,
  • Yoshinori Hasegawa

      Affiliations

    • Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan

Received 29 August 2011; accepted 10 November 2011. published online 05 December 2011.

Summary 

Backgrounds

Bronchoalveolar lavage (BAL) is generally regarded as a safe diagnostic procedure. However, acute exacerbation after BAL is increasingly recognized as a specific complication for patients with idiopathic pulmonary fibrosis (IPF). So far little is known about the correlation between BAL and acute exacerbation of IPF (AE-IPF).

Methods

A cohort of 112 IPF patients at a single institution was analyzed retrospectively. We defined BAL-related AE-IPF as development of AE-IPF within 30 days after the procedure. The incidence rate of AE-IPF per person-month during the post-BAL period was compared with that after the post-BAL period. The relative risk was estimated as the former rate divided by the latter. We also reviewed the previous literature.

Results

Four AE-IPF cases occurred during the 201 person-month post-BAL period. The risk of AE-IPF was significantly elevated within 30 days after BAL (rate ratio = 4.12; 95% CI = 1.03–12.2). None of the 111 initial BAL procedures were followed by AE-IPF within a month. In a post hoc analysis, the relative risk of developing AE after second or later BAL procedures was estimated to be considerably higher (rate ratio = 9.10; 95% CI = 2.27–26.98).

Twelve cases of BAL-induced AE-IPF were found in our study and in the literature review. Among them, nine showed moderate to severe functional impairment, and eight had either findings of leukocytosis, positive C-reactive protein, or neutrophilia in BAL.

Conclusions

These results suggest that IPF patients should be carefully monitored after BAL, especially those with functional impairment or active inflammation.

Keywords: Acute exacerbation, Idiopathic pulmonary fibrosis, Incidence, Bronchoalveolar lavage

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(11)00393-3

doi:10.1016/j.rmed.2011.11.006

Respiratory Medicine
Volume 106, Issue 3 , Pages 436-442, March 2012